|1.||Kimura, Shoji: 2 articles (12/2012 - 05/2005)|
|2.||Kobayashi, Hiroya: 2 articles (12/2012 - 05/2005)|
|3.||Aoki, Naoko: 2 articles (12/2012 - 05/2005)|
|4.||Celis, Esteban: 2 articles (12/2012 - 05/2005)|
|5.||Sato, Keisuke: 2 articles (12/2012 - 05/2005)|
|6.||Hou, Shengping: 2 articles (01/2009 - 01/2008)|
|7.||Du, Liping: 2 articles (01/2009 - 01/2008)|
|8.||Yang, Peizeng: 2 articles (01/2009 - 01/2008)|
|9.||Zhou, Hongyan: 2 articles (01/2009 - 01/2008)|
|10.||Kijlstra, Aize: 2 articles (01/2009 - 01/2008)|
|1.||Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome)
01/01/2009 - "Our study confirms the previous association of HLA-DR4 and HLA-DRw53 with VKH syndrome but fails to demonstrate an association between FCRL3 polymorphisms and VKH syndrome. "
01/01/2009 - "Stratification analysis according to HLA-DR4 and HLA-DRw53 did not show any association of FCRL3 polymorphisms with VKH syndrome. "
01/01/2009 - "HLA-DR4 and HLA-DRw53 were significantly associated with VKH syndrome (p=3.21 x 10(-16) and p=7.08 x 10(-5), respectively). "
01/01/2008 - "HLA-DR4 and HLA-DRw53 are strongly associated with the susceptibility to VKH syndrome in the Chinese Han population. "
01/01/2008 - "Stratification analysis based on HLA-DR4 and HLA-DRw53 did not show any associations between SUMO4 polymorphisms and VKH syndrome, although there was a big difference in the percentage of certain allele and genotype frequencies between HLA-DRw53 negative patients and controls. "
|2.||Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
|3.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/01/1995 - "On the other hand, HLA-DR53 antigen was significantly decreased in the patients as a whole (43.5%) and in the patients with uveitis (36.4%) as compared with the control subjects (69.6%). "
09/01/1990 - "When VKH patients were compared with racially matched controls without disease and patients with other types of uveitis, strong associations with HLA-DR4 and HLA-DRw53 were found. "
07/01/1995 - "The frequency of HLA-DR2 antigen was significantly increased in the patients with uveitis as compared with the control subjects (Pc < 0.0005), whereas HLA-DR53 antigen was significantly decreased (Pc < 0.05). "
|5.||Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/01/1995 - "A molecular analysis was carried out in 63 sequentially diagnosed childhood acute lymphoblastic leukemia (ALL) patients and 1011 controls to investigate the homozygosity rate for HLA-DR53. "
07/15/1999 - "The cross-reactivity between HLA-DR53 and H-2Ek, extensive mimicry of the immunodominant epitope of HLA-DR53 by several carcinogenic viruses, and the extra amount of DNA in the vicinity of the HLA-DRB4 gene argue for the case that HLA-DRB4*01 may be one of the genetic risk factors for childhood ALL."
|1.||HLA-DR4 Antigen (HLA DR4 Antigen)
|2.||DNA (Deoxyribonucleic Acid)
|4.||HLA-DR2 Antigen (HLA DR2 Antigen)
|5.||HLA-DR Antigens (HLA-DR)
|6.||HLA Antigens (Human Leukocyte Antigens)
|8.||HLA-DR7 Antigen (HLA DR7 Antigen)
|9.||HLA-B35 Antigen (HLA B35 Antigen)